Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neuroradiology
Published in: Neuroradiology 9/2004

01-09-2004 | Diagnostic Neuroradiology

MR spectroscopy of cervical spinal cord in patients with multiple sclerosis

Authors: Ayşe Tuba Karagülle Kendi, Funda Uysal Tan, Mustafa Kendi, Sinef Huvaj, Serdar Tellioğlu

Published in: Neuroradiology | Issue 9/2004

Login to get access

Abstract

MR spectroscopy (MRS) of the brain in patients with multiple sclerosis has been well studied. However, in vivo MRS of the spinal cord in patients with MR spectroscopy has not been reported to our knowledge. We performed MRS of normal-appearing cervical spinal cords in multiple sclerosis patients and in healthy controls. N-acetyl aspartate was shown to be reduced within the cervical spinal cord of multiple sclerosis patients when compared with healthy controls. This finding supports axonal loss and damage within even normal-appearing spinal cords of multiple sclerosis patients.
Literature
1.
Tartaglino LM, Friedman DP, Flanders AE, Lublin FD, Knobler RL, Liem M (1995). Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195:725–732PubMed
2.
Nusbaum AO, Fung KM, Atlas SW (2002) White matter diseases and inherited metabolic disorders. In: Atlas AS (ed) Magnetic resonance imaging of the brain and spine, 3 rd edition. Lippincott Williams & Wilkins, Philadelphia, pp 465–484
3.
Sheldon JJ, Siddharthan R, Tobias J, Sheremata WA, Soila K, Viamonte M Jr (1985). MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients. AJNR Am J Neuroradiol 6:683–690
4.
Bot JCJ, Barkhof F, Lycklama, Nijehalt G, van Schaardenburg D, Voskuyl AE, Ader HJ, Pijnenburg JAL, Polman CH, Uitdehaag BMJ, Vermeulen EGJ, Castelijn JA (2002). Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223:46–56PubMed
5.
Honig L, Sheremata W (1989). Magnetic resonance imaging of spinal cord lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry 52:459–466PubMed
6.
Edwards MK, Farlow MR, Stevens JC (1986). Cranial MR in spinal cord MS: diagnosing patients with isolated spinal cord symptoms. AJNR Am J Neuroradiol 7:1003–1005PubMed
7.
Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD (2001). Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57:1248–1252PubMed
8.
Mader I, Roser W, Kappos L, Hagberg G, Seelig J, Raude EW, Steinbrich W (2000). Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. AJNR Am J Neuroradiol 21:1220–1227PubMed
9.
Lee MA, Blamire AM, Pendlebury S et al (2000). Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. Arch Neurol 57:65–70CrossRefPubMed
10.
Gomez-Anson B, MacManus DG, Parker GJM, Davie CA, Barker GJ, Moseley IF, McDonald WI, Miller DH (2000). In vivo H-magnetic resonance spectroscopy of the spinal cord in humans. Neuroradiology 42:515–517CrossRefPubMed
11.
Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997). Axonal damage in acute multiple sclerosis lesions. Brain 120:393–399CrossRefPubMed
12.
Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD (2000). Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48:893–902CrossRefPubMed
13.
Arnold DL, Reiss GT, Matthews PM et al (1994). Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 36:76–82PubMed
14.
De Stefano N, Matthews PM, Fu L et al (1998). Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy. Brain 121:1469–1477CrossRefPubMed
15.
Vink R, Noble LJ, Knoblach SM, Bendall MR, Faden AI (1989). Metabolic changes in rabbit spinal cord after trauma: magnetic resonance spectroscopy studies. Ann Neurol 25:26–31PubMed
Metadata
Title
MR spectroscopy of cervical spinal cord in patients with multiple sclerosis
Authors
Ayşe Tuba Karagülle Kendi
Funda Uysal Tan
Mustafa Kendi
Sinef Huvaj
Serdar Tellioğlu
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 9/2004
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-004-1231-1

Other articles of this Issue 9/2004

Neuroradiology 9/2004 Go to the issue

Diagnostic Neuroradiology

Cerebral perfusion impairment correlates with the decrease of CT density in acute ischaemic stroke

Erratum

MR spectroscopy of cervical spinal cord in patients with multiple sclerosis

Society News

September 2004

Diagnostic Neuroradiology

Evaluation of extracranial-intracranial arterial bypass function with magnetic resonance angiography

Diagnostic Neuroradiology

A quantitative measure of myelination development in infants, using MR images

Diagnostic Neuroradiology

MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo